Pentwater Capital Management’s Pfizer PFE Stock Holding History

Pentwater Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-158,100	Closed	-$4.87M	–	118
2016 Q4	$4.87M	Buy	+158,100	New	+$4.83M	0.06%	82
2016 Q2	–	Sell	-24,242,000	Closed	-$682M	–	115
2016 Q1	$682M	Buy	24,242,000 +14,070,900	+138%	+$402M	5.01%	6
2015 Q4	$312M	Buy	+10,171,100	New	+$320M	2.14%	14
2014 Q1	–	Sell	-105,400	Closed	-$3.06M	–	131
2013 Q4	$3.06M	Hold	105,400	–	–	0.09%	86
2013 Q3	$2.87M	Sell	105,400 -105,400	-50%	-$2.87M	0.08%	85
2013 Q2	$5.6M	Buy	+210,800	New	+$5.82M	0.12%	68

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pentwater Capital Management's PFE Position: Q1 2018 in Review

Pentwater Capital Management sold out of Pfizer (PFE) in Q1 2018, closing a stake of 20,869 shares — an estimated $717K sold.

Pentwater Capital Management first reported a position in PFE in Q2 2013 and held it in 6 quarters. The position peaked at $765M in Q2 2013. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

Pentwater Capital Management reported no remaining Pfizer position as of Q1 2018 after selling out during the quarter.
Pentwater Capital Management sold 20,869 Pfizer shares in Q1 2018, an estimated $717K.
Pentwater Capital Management first reported a position in Pfizer in Q2 2013 and held it in 6 quarters.
Pentwater Capital Management's Pfizer position peaked at $765M in Q2 2013.
2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Pentwater Capital Management's 13F filing for Q1 2018, filed 15 May 2018.